Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Division of Stem Cell Transplantation and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
Sci Immunol. 2020 Jul 10;5(49). doi: 10.1126/sciimmunol.abb1662.
Molecular, cellular, and clinical studies of human inborn errors of immunity have revolutionized our understanding of their pathogenesis, considerably broadened their spectrum of immunological and clinical phenotypes, and enabled successful targeted therapeutic interventions. These studies have also been of great scientific merit, challenging a number of immunological notions initially established in inbred mice while revealing previously unrecognized mechanisms of host defense by leukocytes and other cells and of both innate and adaptive tolerance to self.
对人类先天性免疫缺陷的分子、细胞和临床研究彻底改变了我们对其发病机制的认识,极大地拓宽了其免疫和临床表型谱,并实现了成功的靶向治疗干预。这些研究也具有重要的科学价值,挑战了最初在近交系小鼠中建立的一些免疫学概念,同时揭示了白细胞和其他细胞对宿主防御的以前未被认识的机制,以及对自身的先天和适应性耐受机制。